Interferon-beta injection site reaction: Review of the histology and report of a lupus-like pattern

Journal of the American Academy of Dermatology

Volumn 59, Issue 2 SUPPL., 2008, Pages

  Conroy, Michael ^a   Sewell, Lindsay ^a   Miller, O Fred ^a   Ferringer, Tammie ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON BETA SERINE; STEROID;

ADULT; ARTICLE; CASE REPORT; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INJECTION SITE REACTION; LUPUS LIKE SYNDROME; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT;

ADULT; DRUG ERUPTIONS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; LUPUS ERYTHEMATOSUS, CUTANEOUS; MULTIPLE SCLEROSIS; SKIN;

EID: 46749142490     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.12.013     Document Type: Article

References (19)

1. Bayas A., and Rieckmann P. Managing the adverse effects of interferon-beta therapy in multiple sclerosis. Drug Saf 22 (2000) 149-159
2. Webster G.F., Knobler R.L., Lublin F.D., Kramer E.M., and Hochman L.R. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis. J Am Acad Dermatol 34 2 Pt 2 (1996) 365-367
3. Mehta C.L., Tyler R.J., and Cripps D.J. Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon beta-1b injections. J Am Acad Dermatol 39 (1998) 1024-1028
4. Linden D. Severe Raynaud's phenomenon associated with interferon-beta treatment for multiple sclerosis. Lancet 352 (1998) 878-879
5. Tai Y.J., and Tam M. Fixed drug eruption with interferon-beta-1b. Australas J Dermatol 46 (2005) 154-157
6. Nousari H.C., Kimyai-Asadi A., and Tausk F.A. Subacute cutaneous lupus erythematosus associated with interferon beta-1a. Lancet 352 (1998) 1825-1826
7. Elgart G.W., Sheremata W., and Ahn Y.S. Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum. J Am Acad Dermatol 37 (1997) 553-558
8. Gaines A.R., and Varricchio F. Interferon beta-1b injection site reactions and necroses. Mult Scler 4 (1998) 70-73
9. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology 45 (1995) 1277-1285
10. Walther E.U., and Hohlfeld R. Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology 53 (1999) 1622-1627
11. Feldmann R., Low-Weiser H., Duschet P., and Gschnait F. Necrotizing cutaneous lesions caused by interferon beta injections in a patient with multiple sclerosis. Dermatology 195 (1997) 52-53
12. Radziwill A.J., and Courvoisier S. Severe necrotising cutaneous lesions complicating treatment with interferon beta-1a. J Neurol Neurosurg Psychiatry 67 (1999) 115
13. Sheremata W.A., Taylor J.R., and Elgart G.W. Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b. N Engl J Med 332 (1995) 1584
14. Casoni F., Merelli E., Bedin R., Martella A., Cesinaro A., and Bertolotto A. Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFNbeta 1b. Mult Scler 9 (2003) 420-423
15. Benito-Leon J., Borbujo J., and Cortes L. Cutaneous mucinoses complicating interferon beta-1b therapy. Eur Neurol 47 (2002) 123-124
16. Arnason B.G. Long-term experience with interferon beta-1b (Betaferon) in multiple sclerosis. J Neurol 252 Suppl 3 (2005) iii28-iii33
17. Ziegler V.R., Kränke B., Soyer P., and Aberer W. Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon-beta injection. [in German]. Hautarzt 49 (1998) 310-312
18. Crispin J.C., and Diaz-Jaounen E. Systemic lupus erythematosus induced by therapy with interferon-β in patient with multiple sclerosis. Lupus 14 (2005) 495-496
19. Fruland J.E., Sandermann S., Snow S.N., Friedl A., and Sharata H.H. Skin necrosis with subsequent formation of squamous cell carcinoma after subcutaneous interferon beta injection. J Am Acad Dermatol 37 3 Pt 1 (1997) 488-489